Comparison of the in vitro and in vivo antitumor activities of tumor-draining lymph node lymphocytes and lymphokine-activated killer cells from human oral cancer

Wei Guo,Weiliu Qiu,Ronggen He,Zhiyuan Zhang
IF: 2.808
1999-01-01
Asian Journal of Surgery
Abstract:A comparison of the in vitro and in vivo antitumor activities of tumor-draining lymph node lymphocytes (DNL) and autologous lymphokine activated killer cells (LAK) showed that DNL cells activated in vitro by rIL-2 exhibited higher cytotoxicity to a human tongue cancer cell line (Tca8113) than the same patients' LAK cells (75% and 36%, respectively), when the ratio of effecters to targets was 50:1. According to Winn's method, the inhibition rates of subcutaneously transplanted Tca cells in mice were 74% and 42%. There was significant difference between in vitro and in vivo antitumor activities of the two groups (p < 0.05), suggesting that DNL cells were more available and practicable for adoptive immunotherapy or cancer gene therapy as a recipient.
What problem does this paper attempt to address?